Guardian Bio, Inc
Guardian Bio, Inc., based in Boston, MA, is at the forefront of combining regenerative medicine with immunotherapy to enhance cancer immunity in patients with late-stage solid tumors. The company has developed a proprietary process to generate true cDC1 dendritic cells from patients' own stem cells, known as GuardcDC1s, which aim to restore antigen presentation and improve clinical responses against cancer.
Co-founded by Ananya Zutshi, Richard Barrett, and Karolina Palucka, Guardian Bio leverages their extensive expertise in biomedical engineering, immunology, and cancer research to pioneer innovative therapies. Their commitment to advancing dendritic cell therapy represents a significant step forward in cancer treatment methodologies.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.






